By producing type 2 cytokines [13], ILC2 proves to be a fresh option to induce airway hyperreactivity (AHR), mucus secretion, and eosinophilic aggregation and promote B lymphocytes to generate IgE, which is possible to exacerbate asthma symptoms. Here, IGHE is linked to asthma.